MARKET

SILO

SILO

Silo Pharma Inc
NASDAQ
0.3960
+0.0060
+1.54%
After Hours: 0.3950 -0.001 -0.25% 19:46 05/12 EDT
OPEN
0.3900
PREV CLOSE
0.3900
HIGH
0.4100
LOW
0.3750
VOLUME
338.35K
TURNOVER
--
52 WEEK HIGH
1.130
52 WEEK LOW
0.2210
MARKET CAP
6.44M
P/E (TTM)
-0.7851
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at SILO last week (0504-0508)?
Weekly Report · 2d ago
Silo Pharma files provisional patent for ibogaine-based therapeutics
TipRanks · 5d ago
Psychedelic: Jefferies initiates Compass Pathways with a Buy rating
TipRanks · 5d ago
Silo Pharma Launches Ibogaine-Based TBI Drug Initiative, Files Patent Amid Growing Psychedelic Therapy Push
Benzinga · 6d ago
Silo Pharma files provisional patent for ibogaine-based traumatic brain injury treatment
PUBT · 6d ago
Silo Pharma Files Provisional Patent for Ibogaine-Based Therapeutic Targeting Traumatic Brain Injury
Barchart · 6d ago
Weekly Report: what happened at SILO last week (0427-0501)?
Weekly Report · 05/04 09:42
Psychedelic: FDA awards Compass Pathways priority review voucher
TipRanks · 04/30 18:56
More
About SILO
Silo Pharma, Inc. is a diversified developmental-stage biopharmaceutical and cryptocurrency treasury company. The Company’s therapeutic focus is on addressing underserved conditions, including stress-induced psychiatric disorders, chronic pain, and central nervous system (CNS) diseases. The Company’s portfolio includes programs, such as for PTSD, SP-26 for fibromyalgia and chronic pain, and preclinical assets targeting Alzheimer’s disease and multiple sclerosis. Its lead product candidate, SPC-15, is designed as a novel serotonin 4 (5-HT4) receptor agonist that utilizes biomarkers for treatment of stress-induced psychiatric disorders such as PTSD and anxiety disorders. SPC-14 targets glutamate receptor NDMAR and serotonin 5-HT4 to address cognitive and neuropsychiatric symptoms in Alzheimer’s disease. SPU-16 is a candidate targeting central nervous system (CNS) disorders, with an initial indication for multiple sclerosis.

Webull offers Silo Pharma Inc stock information, including NASDAQ: SILO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SILO stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading SILO stock methods without spending real money on the virtual paper trading platform.